China’s growing economy has proven to be beneficial to many across the country. Some of these benefits include higher living standards, better health and nutrition, and longer life expectancy.
Cannabis News
ChineseInvestors.com, Inc. (CIIX) Aiming to Help Tackle Epilepsy with a CBD Oil-Based Pharmaceutical
ChineseInvestors.com, Inc. (OTCQB: CIIX), a company in the business of providing Chinese-speaking investors with real-time market analysis, commentary, and educational services, recently announced its goals for 2017, stating that it plans to develop a CBD oil-based pharmaceutical that could help with the major problem of epilepsy in China.
ChineseInvestors.com (CIIX) Achieves Exciting Firsts in the Global Cannabis Market
Marijuana use is currently illegal in China, but cannabis-based oils, including hemp-based CBD, are legal, giving CIIX access to a market of almost two billion potential customers in that country.
ChineseInvestors.com, Inc. (CIIX) Presents Obvious Upside
CBD has long been considered to have a broad range of medical benefits. Now, two major studies released in the last four months have scientifically validated the medicinal efficacy of CBD.
ChineseInvestors.com, Inc. (CIIX) Set to Capitalize on Meteoric Growth of CBD Market
With an annual growth rate of nearly 60 percent, CBD oil has become one of the fastest-growing market categories in the country. U.S.-based ChineseInvestors.com, Inc. (OTCQB: CIIX) is set to capitalize on this meteoric growth.
ChineseInvestors.com, Inc. (CIIX) Raises Profile, Increases Revenues from Investor Relations Activity
ChineseInvestors.com, Inc. (OTCQB: CIIX) has been closely monitored for its upside as it competes in the hemp-derived cannabis market. CIIX has launched a cannabidiol (CBD) online store in the free-trade zone of Shanghai and soon it plans to open a brick-and-mortar store in its home market of San Gabriel, California, to market a line of food and nutrition products.
ChineseInvestors.com, Inc. (CIIX) Aims to Become One-Stop-Shop for Chinese MMJ Patients
The company operates the first online Chinese language CBD health product store. Now, two billion Chinese can order their medicine online and have it delivered to their homes.
ChineseInvestors.com, Inc. (CIIX) Pursues Continued Success in CBD Markets
After making a successful investment in the marijuana market, the company recently expanded into the retail and online sale of cannabidiol (CBD), which has become one of the fastest-growing market categories in the United States.
ChineseInvestors.com, Inc. (CIIX) Aims to Excel in CBD Markets
Not satisfied with a 100,000+ user base, a recognizable 18-year-old brand, and a target market in excess of two billion Chinese speaking people, ChineseInvestors.com recently executed a first-to-market milestone by creating the world’s only Chinese language, cannabinoid-based, therapeutic health products online store, http://www.ChineseCBDoil.com.
ChineseInvestors.com, Inc. (CIIX) Primed to Capitalize on Thriving US Cannabis Market
In addition to its San Gabriel store, the company also owns and operates an online store based in the free trade zone of Shanghai, China.
ChineseInvestors.com (CIIX) Growing Rapidly in a Rapidly Growing Market
When looking for growth, it makes sense to look closely at companies that are not only growing rapidly but also growing rapidly in a rapidly growing market. With compound annual growth estimated at nearly 60 percent, the CBD (cannabidiol) industry is arguably the fastest growing market in the world.
ChineseInvestors.com (CIIX) Eyes Expansion in CBD Markets throughout North America
It plans for a brick-and-mortar store in San Gabriel, California, as well as recently incorporating CBD Biotechnology, Inc., in British Columbia, Canada. It also has an online CBD store with hemp-based products located in the free trade zone of Shanghai, China, designed to serve the global Chinese-speaking population.
India Globalization Capital, Inc. (NYSE MKT: IGC) Targets Cannabis-Based Pharmaceuticals
India Globalization Capital, Inc. (NYSE MKT: IGC) is a company in transition, now targeting pharmaceutical development in the U.S., while curtailing other businesses such as electronics trading in Hong Kong. IGC long-term plans are to establish and extend its development of phytocannabinoid-based pharmaceutical products to treat diseases such as epilepsy and cachexia.
Cannabis-Based Therapies with Potential to Dull the Pain of Opioid Abuse
America is in an opioid epidemic. On an average day, 91 Americans will die from an opioid-related overdose. That’s according to the CDC, which also reports that the number of prescription opioids sold in the U.S. has nearly quadrupled since 1999 despite no overall change in the amount of pain reported.
India Globalization Capital, Inc. (NYSE: IGC) is Blazing a Trail with its Cannabis Plus Therapies
The Bethesda, Maryland-based company is a first mover in “combination therapies” that merge cannabinoids with existing drugs to provide more effective remedies.